This week’s post features BIA member organisation Oxford BioMedica, who recently raised £20 million to further develop their opthalmology portfolio.

Oxford BioMedica are a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. This short video highlights their manufacturing facility in Cowley, near Oxford.

Do you have a video you would like the sector to see? Contact us.